课题基金 / 基金详情

项目摘要

项目成果

Elad Ziv的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mammographic density (MD) is a strong risk factor for breast cancer and is also a highly heritable trait with ~60-70% of the variance in due to genetic factors based on twin studies. MD is also higher in families with a strong history of breast cancer. Genome wide association studies (GWAS), which focus on common genetic variants, have identified several single nucleotide polymorphisms (SNPs) associated with MD. However, these SNPs explain a very small fraction of the variance of MD suggesting many other genes are involved. Linkage studies have identified some loci that may be associated with this trait, but no genes have been mapped yet by linkage analysis. Thus, the vast majority of the heritability of mammographic density remains unexplained and is likely due to rare variants. We have recently identified an association between higher mammographic density and Ashkenazi Jewish ancestry. Since Ashkenazi Jews are a founder population genetic mapping in this population may have several advantages. In particular, Ashkenazi Jews share extensive chromosomal segments that are identical by descent (IBD) due to a small number of founders. We propose to leverage the IBD segments to help map loci for mammographic density. In particular, we plan to search for regions that are IBD among Ashkenazi Jewish women in the top quintile of age and body mass index (BMI)-adjusted mammographic density for shared IBD segments and compare these to Ashkenazi Jewish women in the lowest quintile of age and BMI- adjusted mammographic density. We will then select the top regions and sequence them in the high density women and low density comparison group to identify the genetic variants most likely to be associated with this trait.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the clinical implications for ACKR1/DARC associated neutropenia
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: